ClinicalTrials HQ

Institute of Hematology & Blood Diseases Hospital, China

Institute of Hematology & Blood Diseases Hospital, China

Explore linked clinical trials.

285 results ยท Page 1 of 12

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Umbilical Cord Blood Infusion to Promote Hematopoietic and Immune Reconstitution in Children With Relapsed or Refractory Malignant Solid Tumorschildhood malignant neoplasm, neoplasmNot yet recruitingNot applicable2026-10-08NCT07866534
Nutritional Intervention for Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationNutritional and Metabolic Diseases, graft versus host disease, immune system disorder, nutritional deficiency disease, nutritional disorderNot yet recruitingNot applicable2026-09-30NCT07850375
BCMA/CD3 BsAb Therapy for POEMS SyndromeAbnormalities, Multiple, Blood Protein Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, POEMS syndrome, hematologic disorder, immune system disorder, immunoproliferative disorder, monoclonal gammopathy, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathyRecruitingPhase 22026-09-29NCT07115654
Immunotargeted Therapy Plus Low-Dose Chemotherapy in Newly Diagnosed Adult Ph+ B-ALLPh+ Acute Lymphoblastic Leukemia (Ph+ALL)Not yet recruitingPhase 22026-09-25NCT07840976
Human Albumin Combined With Plasma Exchange for Frailty InterventionFrailty, Pathologic Processes, Pathological Conditions, Signs and SymptomsNot yet recruitingNot applicable2026-09-23NCT07836127
Rituximab, Pirtobrutinib, Lisaftoclax and Liposomal Mitoxantrone for for Richter Syndrome Transformed From CLLRichter transformationNot yet recruitingPhase 22026-09-21NCT07831395
CM336 Plus Daratumumab and Lenalidomide in Transplant-Ineligible Newly Diagnosed Multiple MyelomaBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseNot yet recruitingPhase 22026-09-21NCT07830485
Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic AnemiaBone Marrow Failure Disorders, Hemic and Lymphatic Diseases, anemia, aplastic anemia, bone marrow disorder, hematologic disorderRecruitingPhase 1 / Phase 22026-09-21NCT07714512
A Clinical Study on the Efficacy and Safety of Zeprumetostat in Relapsed/Refractory Large Granular Lymphocyte LeukemiaHemic and Lymphatic Diseases, Leukemia, Large Granular Lymphocytic, Neoplasms by Histologic Type, T-cell leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmNot yet recruitingPhase 12026-09-21NCT07692529
META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic AnemiaHemic and Lymphatic Diseases, anemia, autoimmune disease, autoimmune hemolytic anemia, hematologic disorder, hemolytic anemia, immune system disorderNot yet recruitingEarly phase 12026-09-21NCT07689604
Liposomal Mitoxantrone Plus Azacitidine and Venetoclax in Newly Diagnosed Elderly or Unfit AMLHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmNot yet recruitingPhase 12026-09-18NCT07828535
F182112 in Combination With Isatuximab and Lenalidomide for the Treatment of Patients With Newly Diagnosed Multiple MyelomaBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseNot yet recruitingPhase 22026-09-18NCT07828522
CS1-Targeted CAR-T Cells for Relapsed/Refractory Multiple MyelomaBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell myeloma, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseActive, not recruitingPhase 12026-09-18NCT07809594
CM336 Plus Isa-VR in Newly Diagnosed Primary Plasma Cell LeukemiaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphoproliferative syndrome, neoplasm, plasma cell leukemia, plasma cell neoplasmRecruitingPhase 22026-09-18NCT07652905
Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRSBone Marrow Failure Disorders, Hemic and Lymphatic Diseases, anemia, aplastic anemia, autoimmune disease, autoimmune hemolytic anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, immune system disorder, myelodysplastic syndromeRecruitingNot stated2026-09-18NCT07578675
GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell MalignanciesHemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasmRecruitingPhase 1 / Phase 22026-09-18NCT06948981
Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With ThalassemiaCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Puberty, Delayed, Thalassemia Intermedia, Thalassemia Major, anemia, beta thalassemia, endocrine system disorder, familial hemolytic anemia, gonadal disorder, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, thalassemiaActive, not recruitingNot applicable2026-09-18NCT06931912
CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal ImpairmentBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingPhase 22026-09-17NCT07585760
Phase 1 Study of F182112 in Relapsed/Refractory Autoimmune Hemolytic AnemiaHemic and Lymphatic Diseases, anemia, autoimmune disease, autoimmune hemolytic anemia, hematologic disorder, hemolytic anemia, immune system disorderNot yet recruitingPhase 12026-09-11NCT07816341
Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell LymphomaB-cell neoplasm, Digestive System Diseases, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, digestive system disorder, histiocytosis, hypertrophic pyloric stenosis, immune system disorder, immunoproliferative disorder, interdigitating dendritic cell sarcoma, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, malignant histiocytosis, neoplasm, primary mediastinal large B-cell lymphoma, pyloric stenosis, stomach disorderRecruitingPhase 12026-09-11NCT06830031
HP-001 Plus Dexamethasone for Relapsed/Refractory Multiple Myeloma With Extramedullary DiseaseBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseNot yet recruitingPhase 22026-09-10NCT07811986
A Study of Bometase Alfa for Bleeding Control in Acquired Hemophilia Aacquired hemophilia ANot yet recruitingNot applicable2026-08-27NCT07789587
Safety and Efficacy of Elranatamab Plus Isatuximab, Bortezomib, and Lenalidomide in Ultra-High-Risk Multiple MyelomaBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseNot yet recruitingPhase 22026-08-27NCT07789522
A Study of Elranatamab for Inhibitor Eradication in Patients With Hemophilia ACongenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorderNot yet recruitingNot applicable2026-08-26NCT07788469
Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune ThrombocytopeniaCytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathyRecruitingPhase 42026-08-26NCT07788456